Discontinuation report MENACTRA

Last updated on 2025-06-05 History
Report ID 258386
Drug Identification Number 02279924
Brand name MENACTRA
Common or Proper name Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP C MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP Y MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP W 135 MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP A
Strength(s) 4.0MCG 4.0MCG 4.0MCG 4.0MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 0.5 mL vial
ATC code J07AH
ATC description BACTERIAL VACCINES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2025-04-01
Actual discontinuation date 2025-04-01
Remaining supply date 2025-08-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Remaining supply date is August 31, 2025
Company comments Menactra is substituted by MenQuadfi (DIN #02507161).
Health Canada comments
Tier 3 Status No
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-06-05 French Compare
v5 2025-06-05 English Compare
v4 2025-06-05 English Compare
v3 2025-05-28 French Compare
v2 2025-05-28 English Compare
v1 2025-05-28 English Compare

Showing 1 to 6 of 6